Related Experiment Video
Updated: Dec 5, 2025

Magnetic Resonance Derived Myocardial Strain Assessment Using Feature Tracking
Published on: February 12, 2011
Cardiac magnetic resonance T2 mapping and feature tracking in athlete's heart and HCM
Mareike Gastl1, Vera Lachmann2, Aikaterini Christidi2
1Department of Cardiology, Pulmonology and Vascular Medicine, Heinrich Heine University Düsseldorf, Moorenstraße 5, Düsseldorf, 40225, Germany. Mareike.Cramer@med.uni-duesseldorf.de.
Insights
Cardiovascular magnetic resonance (CMR) with T2 mapping and deformation imaging can differentiate hypertrophic cardiomyopathy (HCM) from athlete's heart (AH). These advanced imaging techniques help distinguish pathological left ventricular hypertrophy (LVH) in athletes for better risk assessment.
Area of Science:
- Cardiology
- Medical Imaging
- Sports Medicine
Background:
- Distinguishing hypertrophic cardiomyopathy (HCM) from athlete's heart (AH), a form of left ventricular hypertrophy (LVH) due to training, is challenging based on morphology alone.
- Accurate differentiation is crucial for risk assessment in competitive athletes.
Purpose of the Study:
- To evaluate the utility of T2 mapping and deformation imaging via cardiovascular magnetic resonance (CMR) in differentiating AH from HCM (both obstructive and non-obstructive).
Main Methods:
- CMR including T2 mapping and strain analysis (global longitudinal strain - GLS) was performed on patients with HCM (HOCM/HNCM) and strength-trained athletes (AH).
- Left ventricular (LV) parameters such as LV mass index (LVMi) and interventricular septum thickness (IVS) were assessed.
- T2 values and GLS were analyzed and compared between groups.
Main Results:
- While LVMi did not differ, interventricular septum thickness was greater in HOCM patients compared to athletes.
- Global longitudinal strain (GLS) was significantly higher in HCM patients (HOCM/HNCM) than in athletes (AH).
- Median T2 values were elevated in HCM patients compared to controls, but not in athletes. ROC analysis showed T2 values (AUC 0.78) and GLS (AUC 0.91) effectively discriminate AH from HCM.
Conclusions:
- Multiparametric CMR, incorporating T2 mapping and deformation imaging, provides valuable information to distinguish athlete's heart from hypertrophic cardiomyopathy.
- These advanced CMR techniques aid in differentiating pathological LVH from physiological changes in athletes, impacting sports participation decisions.
Objectives:
Distinguishing hypertrophic cardiomyopathy (HCM) from left ventricular hypertrophy (LVH) due to systematic training (athlete's heart, AH) from morphologic assessment remains challenging. The purpose of this study was to examine the role of T2 mapping and deformation imaging obtained by cardiovascular magnetic resonance (CMR) to discriminate AH from HCM with (HOCM) or without outflow tract obstruction (HNCM).
Methods:
Thirty-three patients with HOCM, 9 with HNCM, 13 strength-trained athletes as well as individual age- and gender-matched controls received CMR. For T2 mapping, GRASE-derived multi-echo images were obtained and analyzed using dedicated software. Besides T2 mapping analyses, left ventricular (LV) dimensional and functional parameters were obtained including LV mass per body surface area (LVMi), interventricular septum thickness (IVS), and global longitudinal strain (GLS).
Results:
While LVMi was not significantly different, IVS was thickened in HOCM patients compared to athlete's. Absolute values of GLS were significantly increased in patients with HOCM/HNCM compared to AH. Median T2 values were elevated compared to controls except in athlete's heart. ROC analysis revealed T2 values (AUC 0.78) and GLS (AUC 0.91) as good parameters to discriminate AH from overall HNCM/HOCM.
Conclusion:
Discrimination of pathologic from non-pathologic LVH has implications for risk assessment of competitive sports in athletes. Multiparametric CMR with parametric T2 mapping and deformation imaging may add information to distinguish AH from LVH due to HCM.
Key Points:
• Structural analyses using T2 mapping cardiovascular magnetic resonance imaging (CMR) may help to further distinguish myocardial diseases. • To differentiate pathologic from non-pathologic left ventricular hypertrophy, CMR including T2 mapping was obtained in patients with hypertrophic obstructive/non-obstructive cardiomyopathy (HOCM/HNCM) as well as in strength-trained athletes. • Elevated median T2 values in HOCM/HNCM compared with athlete's may add information to distinguish athlete's heart from pathologic left ventricular hypertrophy.
More Related Videos
11:13Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging
Published on: May 24, 2021
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Magnetic Resonance Imaging
Imaging Studies for Cardiovascular System IV: CMRI
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests